Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2021 11:45 ET | Source: Kiadis Pharma Netherlands B.V.

Notice of Annual General Meeting of Shareholders

Amsterdam, The Netherlands, 13 May 2021 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announces that...
April 29, 2021 01:00 ET | Source: Kiadis Pharma Netherlands B.V.

Final results of the Offer for Kiadis: 97.39% of Kiadis Shares in total committed under the Offer

This is a joint press release by Sanofi Foreign Participations B.V. (the “Offeror”), Sanofi (“Sanofi”) and Kiadis Pharma N.V. (“Kiadis”), pursuant to the provisions of Article 17 paragraph 4 of the...
April 26, 2021 12:00 ET | Source: Kiadis Pharma Netherlands B.V.

Delisting of Kiadis will be effective on 25 May 2021

This is a joint press release by Sanofi Foreign Participations B.V. (the “Offeror”), Sanofi (“Sanofi”) and Kiadis Pharma N.V. (“Kiadis”) in connection with the recommended public offer by the Offeror...
April 16, 2021 12:00 ET | Source: Kiadis Pharma Netherlands B.V.

Sanofi completes Kiadis acquisition

This is a joint press release by Sanofi Foreign Participations B.V. (the “Offeror”), Sanofi (“Sanofi”) and Kiadis Pharma N.V. (“Kiadis”) in connection with the public offer by the Offeror for all the...
April 13, 2021 01:00 ET | Source: Kiadis Pharma Netherlands B.V.

Sanofi declares the Offer for Kiadis unconditional

This is a joint press release by Sanofi Foreign Participations B.V. (the “Offeror”), Sanofi (“Sanofi”) and Kiadis Pharma N.V. (“Kiadis”), pursuant to the provisions of Article 16, paragraph 1 and 2...
April 09, 2021 01:00 ET | Source: Kiadis Pharma Netherlands B.V.

Kiadis employee options committed under the Sanofi Offer

This is a press release by Kiadis Pharma N.V. (“Kiadis”), pursuant to the provisions of Section 5 paragraphs 4 and 5 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) (the...
April 07, 2021 11:45 ET | Source: Kiadis Pharma Netherlands B.V.

Kiadis Pharma announces annual results for the year ended December 31, 2020

New strategic focus results in significant progress in cell based therapies Amsterdam, The Netherlands, April 7, 2021 – Kiadis Pharma N.V. (“Kiadis”,...
March 30, 2021 07:48 ET | Source: Kiadis Pharma Netherlands B.V.

Kiadis EGM adopts all resolutions related to the recommended public offer by Sanofi

This is a press release by Kiadis Pharma N.V. (“Kiadis”) in connection with the public offer by Sanofi Foreign Participations B.V. (“the Offeror”), a wholly owned subsidiary of Sanofi (“Sanofi”), for...
February 15, 2021 11:45 ET | Source: Kiadis Pharma Netherlands B.V.

Kiadis issues shares to Kreos Capital following agreed conversion of convertible bonds

This is a press release by Kiadis Pharma N.V. (“Kiadis”), pursuant to the provisions of Section 5 paragraphs 4 and 5 and Section 6 paragraph 2 of the Dutch Decree on Public Takeover Bids (Besluit...
February 12, 2021 01:00 ET | Source: Kiadis Pharma Netherlands B.V.

Sanofi launches recommended cash offer for all shares in Kiadis

This is a joint press release by Sanofi Foreign Participations B.V. (the “Offeror”), Sanofi (“Sanofi”) and Kiadis Pharma N.V. (“Kiadis”), pursuant to the provisions of Article 4 paragraph 1, Article...